Search bioRxivSearch

Biology subjects

Agurto, C.

Publications and source records attributed to Agurto, C..

2 recordsLinked to original sources

Speech-based identification of L-DOPA ON/OFF state in Parkinson’s Disease subjects

BackgroundParkinsons disease patients (PDP) are evaluated using the unified Parkinsons disease rating scale (UP-DRS) to follow the longitudinal course of the disease. UP-DRS evaluation is performed by a neurologist, and hence its use is limited in the evaluation of short-term (daily) fluctuations. Subjects taking L-DOPA as part of treatment to reduce symptoms exhibit motor fluctuations as a common complication.\n\nObjectivesThe aim of the study is to assess the use of speech analysis as a proxy to continuously monitor PDP medication state.\n\nMethodsWe combine acoustic, prosody, and semantic features to characterize three speech tasks (picture description, reverse counting and diadochokinetic rate) of 25 PDP evaluated under different medication states: \"ON\" and \"OFF\" L-DOPA.\n\nResultsClassification of medication states using features extracted from audio recordings results in cross-validated accuracy rates of 0.88, 0.84 and 0.71 for the picture description, reverse counting and diadochokinetic rate tasks, respectively. When adding feature selection and semantic features, the accuracy rates increase to 1.00, 0.96 and 0.83 respectively; thus reaching very high classification accuracy on 3 different tasks.\n\nConclusionsWe show that speech-based features are highly predictive of medication state. Given that the highest performance was obtained with a very naturalistic task (picture description), our results suggest the feasibility of accurate, non-burdensome and high-frequency monitoring of medication effects.

neuroscience

Detection of Amyotrophic Lateral Sclerosis (ALS) via Acoustic Analysis

ALS is a fatal neurodegenerative disease with no cure. Experts typically measure disease progression via the ALSFRS-R score, which includes measurements of various abilities known to decline. We propose instead the use of speech analysis as a proxy for ALS progression. This technique enables 1) frequent non-invasive, inexpensive, longitudinal analysis, 2) analysis of data recorded in the wild, and 3) creation of an extensive ALS databank for future analysis. Patients and trained medical professionals need not be co-located, enabling more frequent monitoring of more patients from the convenience of their own homes. The goals of this study are the identification of acoustic speech features in naturalistic contexts which characterize disease progression and development of machine models which can recognize the presence and severity of the disease. We evaluated subjects from the Prize4Life Israel dataset, using a variety of frequency, spectral, and voice quality features. The dataset was generated using the ALS Mobile Analyzer, a cell-phone app that collects data regarding disease progress using a self-reported ALSFRS-R questionnaire and several active tasks that measure speech and motor skills. Classification via leave-five-subjects-out cross-validation resulted in an accuracy rate of 79% (61% chance) for males and 83% (52% chance) for females.

neuroscience